i
Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
-
5 2022
-
-
Source: Emerg Infect Dis. 2022; 28(5):1050-1052
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizing activity was comparable to that after 3-dose vaccination. Shorter intervals between vaccination and breakthrough infection correlated with lower neutralizing titers.
-
Subjects:
-
Source:
-
Pubmed ID:35259088
-
Pubmed Central ID:PMC9045428
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: